Literature DB >> 23246686

Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.

Jeffrey R Garber1, Rhoda H Cobin, Hossein Gharib, James V Hennessey, Irwin Klein, Jeffrey I Mechanick, Rachel Pessah-Pollack, Peter A Singer, Kenneth A Woeber.   

Abstract

OBJECTIVE: Hypothyroidism has multiple etiologies and manifestations. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions. This paper describes evidence-based clinical guidelines for the clinical management of hypothyroidism in ambulatory patients.
METHODS: The development of these guidelines was commissioned by the American Association of Clinical Endocrinologists (AACE) in association with American Thyroid Association (ATA). AACE and the ATA assembled a task force of expert clinicians who authored this article. The authors examined relevant literature and took an evidence-based medicine approach that incorporated their knowledge and experience to develop a series of specific recommendations and the rationale for these recommendations. The strength of the recommendations and the quality of evidence supporting each was rated according to the approach outlined in the American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Guidelines-2010 update.
RESULTS: Topics addressed include the etiology, epidemiology, clinical and laboratory evaluation, management, and consequences of hypothyroidism. Screening, treatment of subclinical hypothyroidism, pregnancy, and areas for future research are also covered.
CONCLUSIONS: Fifty-two evidence-based recommendations and subrecommendations were developed to aid in the care of patients with hypothyroidism and to share what the authors believe is current, rational, and optimal medical practice for the diagnosis and care of hypothyroidism. A serum thyrotropin is the single best screening test for primary thyroid dysfunction for the vast majority of outpatient clinical situations. The standard treatment is replacement with L-thyroxine. The decision to treat subclinical hypothyroidism when the serum thyrotropin is less than 10 mIU/L should be tailored to the individual patient.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246686     DOI: 10.4158/EP12280.GL

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  249 in total

Review 1.  United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies.

Authors:  Woondong Jeong; James H Doroshow; Shivaani Kummar
Journal:  Curr Probl Cancer       Date:  2013 May-Jun       Impact factor: 3.187

Review 2.  Thyroid hormone therapy of hypothyroidism in pregnancy.

Authors:  Zhongyan Shan; Weiping Teng
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

Review 3.  Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.

Authors:  Meritxell Tost; José Antonio Monreal; Antonio Armario; Juan David Barbero; Jesús Cobo; Clemente García-Rizo; Miquel Bioque; Judith Usall; Elena Huerta-Ramos; Virginia Soria; Javier Labad
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859

4.  Clinical features of immune-related thyroid dysfunction and its association with outcomes in patients with advanced malignancies treated by PD-1 blockade.

Authors:  Tomoki Sakakida; Takeshi Ishikawa; Junji Uchino; Yusuke Chihara; Satoshi Komori; Jun Asai; Tsukasa Narukawa; Akihito Arai; Tsutomu Kobayashi; Hiroaki Tsunezuka; Toshiyuki Kosuga; Hirotaka Konishi; Fumiya Hongo; Masayoshi Inoue; Shigeru Hirano; Osamu Ukimura; Yoshito Itoh; Tetsuya Taguchi; Koichi Takayama
Journal:  Oncol Lett       Date:  2019-06-12       Impact factor: 2.967

5.  Drug interactions with levothyroxine therapy in patients with hypothyroidism: observational study in general practice.

Authors:  Gianluca Trifirò; Fabrizio Parrino; Janet Sultana; Francesco Giorgianni; Carmen Ferrajolo; Elisa Bianchini; Gerardo Medea; Salvatore Benvenga; Iacopo Cricelli; Claudio Cricelli; Francesco Lapi
Journal:  Clin Drug Investig       Date:  2015-03       Impact factor: 2.859

6.  Thyroid function testing in patients with newly diagnosed hyperlipidemia.

Authors:  Devina L Willard; Angela M Leung; Elizabeth N Pearce
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

7.  Thyroid-Stimulating Hormone in the Evaluation of Subclinical Hypothyroidism.

Authors:  Maria Papaleontiou; Anne R Cappola
Journal:  JAMA       Date:  2016-10-18       Impact factor: 56.272

8.  Physician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics.

Authors:  Jacqueline Jonklaas; Eshetu Tefera; Nawar Shara
Journal:  Thyroid       Date:  2018-11       Impact factor: 6.568

9.  Investigating the optimal preconception TSH range for patients undergoing IVF when controlling for embryo quality.

Authors:  Katherine A Green; Marie D Werner; Jason M Franasiak; Caroline R Juneau; Kathleen H Hong; Richard T Scott
Journal:  J Assist Reprod Genet       Date:  2015-08-18       Impact factor: 3.412

10.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.